FDA Advisory Board

Shares of Vanda Pharmaceuticals (NASDAQ: VNDA) traded up more than 29 percent following the company's 8-K filing on Wednesday and Exhibit 99.1 presentation. History of the Drug Application On May 31, 2013, Vanda announced that it submitted a new drug application to the Food and Drug...